Title |
Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand
|
---|---|
Published in |
BMC Infectious Diseases, March 2013
|
DOI | 10.1186/1471-2334-13-114 |
Pubmed ID | |
Authors |
Leonardo M Simonella, Hazel Lewis, Megan Smith, Harold Neal, Collette Bromhead, Karen Canfell |
Abstract |
The national Human Papillomavirus (HPV) Immunisation Programme in New Zealand was introduced in 2008, and involves routine vaccination of girls 12-13 years with a catch-up for females aged up to 19 years. The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 40% |
New Zealand | 1 | 20% |
United Kingdom | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 57 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 13 | 22% |
Student > Master | 9 | 16% |
Researcher | 7 | 12% |
Student > Ph. D. Student | 6 | 10% |
Student > Postgraduate | 4 | 7% |
Other | 7 | 12% |
Unknown | 12 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 33 | 57% |
Nursing and Health Professions | 3 | 5% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Agricultural and Biological Sciences | 2 | 3% |
Immunology and Microbiology | 2 | 3% |
Other | 3 | 5% |
Unknown | 13 | 22% |